Literature DB >> 9836024

Enhanced behavioral response to repeated d-amphetamine and personality traits in humans.

K W Sax1, S M Strakowski.   

Abstract

BACKGROUND: This study examined whether the magnitude of the behavioral response to repeated d-amphetamine administration previously demonstrated in a double-blind study in humans was associated with certain personality characteristics.
METHODS: Eleven normal volunteers completed the Tridimensional Personality Questionnaire (TPQ) prior to being administered three doses of d-amphetamine (0.25 mg/kg) alternating with three doses of placebo over 6 consecutive days. Behavioral measures included eye-blink rates as well as ratings of elevated mood, increased motor activity/energy, and increased speech. These variables were assessed once prior to dosing, then hourly for 5 hours.
RESULTS: A greater magnitude of change in elevated mood over the three amphetamine doses significantly correlated with ratings of the Novelty Seeking on the TPQ.
CONCLUSIONS: These results suggest that similar to findings in animal models, there are certain intrinsic behavioral characteristics that are associated with amphetamine sensitivity in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836024     DOI: 10.1016/s0006-3223(98)00168-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  14 in total

1.  Factors regulating eye blink rate in young infants.

Authors:  Leigh F Bacher
Journal:  Optom Vis Sci       Date:  2010-05       Impact factor: 1.973

2.  Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status.

Authors:  Thomas H Kelly; Glenn Robbins; Catherine A Martin; Mark T Fillmore; Scott D Lane; Nancy G Harrington; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

3.  Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty.

Authors:  Laurel M Pritchard; Aaron D Logue; Benjamin C Taylor; Rebecca Ahlbrand; Jeffrey A Welge; Yang Tang; Frank R Sharp; Neil M Richtand
Journal:  Brain Res Bull       Date:  2006-07-13       Impact factor: 4.077

4.  Personality and the acute subjective effects of d-amphetamine in humans.

Authors:  Matthew G Kirkpatrick; Chris-Ellyn Johanson; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2013-01-23       Impact factor: 4.153

5.  Levodopa administration modulates striatal processing of punishment-associated items in healthy participants.

Authors:  Bianca C Wittmann; Mark D'Esposito
Journal:  Psychopharmacology (Berl)       Date:  2014-06-13       Impact factor: 4.530

6.  Differential housing and novelty response: Protection and risk from locomotor sensitization.

Authors:  Erik J Garcia; Tara N Haddon; Donald A Saucier; Mary E Cain
Journal:  Pharmacol Biochem Behav       Date:  2017-01-17       Impact factor: 3.533

7.  Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine.

Authors:  Ronald Kuczenski; David S Segal
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

8.  Inhibition of mitochondrial respiratory chain in the brain of adult rats after acute and chronic administration of methylphenidate.

Authors:  Ana O Fagundes; Giselli Scaini; Patricia M Santos; Monique U Sachet; Nayara M Bernhardt; Gislaine T Rezin; Samira S Valvassori; Patrícia F Schuck; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

9.  Dopamine, norepinephrine, and the management of sensorimotor bindings: individual differences in updating of stimulus-response episodes are predicted by DAT1, but not DBH5'-ins/del.

Authors:  Lorenza S Colzato; Sharon Zmigrod; Bernhard Hommel
Journal:  Exp Brain Res       Date:  2013-05-17       Impact factor: 1.972

10.  Performance and subjective effects of diazepam and d-amphetamine in high and low sensation seekers.

Authors:  Thomas H Kelly; Timothy A Delzer; Catherine A Martin; Nancy G Harrington; Lon R Hays; Michael T Bardo
Journal:  Behav Pharmacol       Date:  2009-09       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.